Skip to main content
. Author manuscript; available in PMC: 2011 Jun 1.
Published in final edited form as: Obesity (Silver Spring). 2009 Oct 29;18(6):1201–1211. doi: 10.1038/oby.2009.360

Figure 1.

Figure 1

The proposed conceptual pathogenetic model includes the disease of obesity as the clinical endpoint, satiation as the surrogate endpoint, and gastric motor functions and gastrointestinal hormones as biomarkers or endophenotype, subject to modulation by the genotype.

HHS Vulnerability Disclosure